FGFR1 and neoplasm: Overexpression or abnormal splicing of FGFR1 can promote EMT, enhance invasion and metastasis ability, and drive cell proliferation through MAPK/ERK or COX-2 pathways, which is closely related to tumor malignancy progression (43–45).